CR11572A - Derivados del acido fenilacetico como moduladores de la inflamacion - Google Patents
Derivados del acido fenilacetico como moduladores de la inflamacionInfo
- Publication number
- CR11572A CR11572A CR11572A CR11572A CR11572A CR 11572 A CR11572 A CR 11572A CR 11572 A CR11572 A CR 11572A CR 11572 A CR11572 A CR 11572A CR 11572 A CR11572 A CR 11572A
- Authority
- CR
- Costa Rica
- Prior art keywords
- derivatives
- modulators
- inflammation
- phenylacetic acid
- compounds
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 208000012657 Atopic disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US843307P | 2007-12-19 | 2007-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR11572A true CR11572A (es) | 2010-08-13 |
Family
ID=40564868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR11572A CR11572A (es) | 2007-12-19 | 2010-07-19 | Derivados del acido fenilacetico como moduladores de la inflamacion |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8183293B2 (enExample) |
| EP (1) | EP2231595B1 (enExample) |
| JP (1) | JP5437267B2 (enExample) |
| KR (1) | KR20100102668A (enExample) |
| CN (1) | CN101903338A (enExample) |
| AR (1) | AR071279A1 (enExample) |
| AU (1) | AU2008343924B2 (enExample) |
| BR (1) | BRPI0821197A2 (enExample) |
| CA (1) | CA2707789A1 (enExample) |
| CL (1) | CL2008003832A1 (enExample) |
| CO (1) | CO6321234A2 (enExample) |
| CR (1) | CR11572A (enExample) |
| EA (1) | EA201001029A1 (enExample) |
| ES (1) | ES2471919T3 (enExample) |
| IL (1) | IL206069A0 (enExample) |
| MA (1) | MA32013B1 (enExample) |
| PE (1) | PE20091526A1 (enExample) |
| TN (1) | TN2010000223A1 (enExample) |
| TW (1) | TW200940051A (enExample) |
| WO (1) | WO2009085177A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| CN104114169A (zh) | 2011-12-16 | 2014-10-22 | 阿托佩斯治疗有限公司 | 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物 |
| US9974759B2 (en) * | 2013-05-31 | 2018-05-22 | Indiana University Research And Technology Corporation | Beta 2 adrenoceptor antagonists for treating orthostatic hypotension |
| EP3256121B1 (en) * | 2015-02-13 | 2024-08-07 | INSERM - Institut National de la Santé et de la Recherche Médicale | Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus |
| LT3433234T (lt) | 2016-03-22 | 2021-12-10 | Merck Sharp & Dohme Corp. | Nikotino acetilcholino receptorių alosteriniai moduliatoriai |
| EP3424927B1 (en) | 2017-07-04 | 2019-04-17 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Efficient process for the preparation of sitagliptin through a very effective preparation of the intermediate 2,4,5-trifluorophenylacetic acid |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8704158D0 (en) | 1987-02-23 | 1987-04-01 | Wellcome Found | Substituted hydantoin compounds |
| US5849780A (en) | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| US5776951A (en) | 1993-06-30 | 1998-07-07 | Glaxo Wellcome Inc. | Anti-atherosclerotic diaryl compounds |
| US5545669A (en) | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
| EP0799206B1 (en) | 1994-12-20 | 2002-09-11 | F. Hoffmann-La Roche Ag | Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| US6008234A (en) | 1996-09-12 | 1999-12-28 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| EP0929547B1 (en) | 1996-09-12 | 2002-11-27 | Schering Aktiengesellschaft | Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| JPH11202458A (ja) | 1998-01-16 | 1999-07-30 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| US5929250A (en) | 1997-01-23 | 1999-07-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| AU3665199A (en) | 1998-04-29 | 1999-11-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of impdh enzyme |
| AR023659A1 (es) | 1998-09-18 | 2002-09-04 | Vertex Pharma | Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos |
| US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
| CZ20013117A3 (cs) | 1999-03-01 | 2002-06-12 | Pfizer Products Inc. | Oxamové kyseliny a jejich deriváty jako ligandy thyreoidního receptoru |
| WO2000053573A1 (en) | 1999-03-10 | 2000-09-14 | Shionogi & Co., Ltd. | Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors |
| US6884593B1 (en) | 1999-08-23 | 2005-04-26 | Bml, Inc. | Method of identifying properties of substance with respect to human prostaglandin D2 receptors |
| US6531291B1 (en) | 1999-11-10 | 2003-03-11 | The Trustees Of Columbia University In The City Of New York | Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof |
| US20020072530A1 (en) | 2000-02-01 | 2002-06-13 | Bing-Yan Zhu | Indole and benzimidazole inhibitors of factor Xa |
| US20010047027A1 (en) | 2000-04-12 | 2001-11-29 | Marc Labelle | Prostaglandin D2 receptor antagonists |
| WO2001094309A1 (en) | 2000-06-02 | 2001-12-13 | Shionogi & Co., Ltd. | Drug composition antagonistic to both pgd2/txa2 receptors |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| AU2002229611A1 (en) | 2000-12-08 | 2002-06-18 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells |
| CA2433100A1 (en) | 2000-12-27 | 2002-07-04 | Helmut Haning | Indole derivatives as ligands of thyroid receptors |
| AU2002302248B2 (en) | 2001-05-23 | 2008-03-06 | Merck Frosst Canada Ltd. | Dihydropyrrolo[1,2-A]indole and tetrahydropyrido[1,2-A]-indole derivatives as prostaglandin D2 receptor antagonists |
| PL368129A1 (en) | 2001-08-09 | 2005-03-21 | Ono Pharmaceutical Co, Ltd. | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| MXPA04009095A (es) | 2002-03-19 | 2004-12-06 | Ono Pharmaceutical Co | Compuesto de acido carboxilico y agente farmaceutico que comprende el compuesto como ingrediente activo. |
| WO2003097598A1 (en) | 2002-05-16 | 2003-11-27 | Shionogi & Co., Ltd. | Compound exhibiting pgd 2 receptor antagonism |
| WO2003097042A1 (en) | 2002-05-16 | 2003-11-27 | Shionogi & Co., Ltd. | Pgd2 receptor antagonist |
| GB2388540A (en) | 2002-05-17 | 2003-11-19 | Bayer Ag | New use of Ramatroban |
| SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| MXPA05006701A (es) * | 2002-12-20 | 2006-03-30 | Amgen Inc | Moduladores de asma y de inflacion alergica. |
| DE602004011985T2 (de) | 2003-11-25 | 2009-03-05 | Eli Lilly And Co., Indianapolis | Modulatoren des peroxisomproliferatoraktivierten rezeptors |
| EP1937632A1 (en) * | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Novel compounds |
| BRPI0720254A2 (pt) * | 2006-12-15 | 2014-01-07 | Glaxo Group Ltd | Derivados de benzamida como agonistas do receptor ep4 |
| US7960567B2 (en) | 2007-05-02 | 2011-06-14 | Amgen Inc. | Compounds and methods useful for treating asthma and allergic inflammation |
| WO2011014587A2 (en) | 2009-07-31 | 2011-02-03 | Amira Pharmaceuticals, Inc. | Ophthalmic pharmaceutical compositions of dp2 receptor antagonists |
| KR20120046762A (ko) | 2009-07-31 | 2012-05-10 | 판미라 파마슈티칼스, 엘엘씨 | Ｄｐ2 수용체 길항제의 피부 제형 |
-
2008
- 2008-12-18 EP EP08867490.8A patent/EP2231595B1/en active Active
- 2008-12-18 CN CN2008801215268A patent/CN101903338A/zh active Pending
- 2008-12-18 JP JP2010539482A patent/JP5437267B2/ja not_active Expired - Fee Related
- 2008-12-18 KR KR1020107015813A patent/KR20100102668A/ko not_active Withdrawn
- 2008-12-18 EA EA201001029A patent/EA201001029A1/ru unknown
- 2008-12-18 BR BRPI0821197-3A patent/BRPI0821197A2/pt not_active IP Right Cessation
- 2008-12-18 US US12/317,066 patent/US8183293B2/en active Active
- 2008-12-18 ES ES08867490.8T patent/ES2471919T3/es active Active
- 2008-12-18 CA CA2707789A patent/CA2707789A1/en not_active Abandoned
- 2008-12-18 WO PCT/US2008/013833 patent/WO2009085177A1/en not_active Ceased
- 2008-12-18 AU AU2008343924A patent/AU2008343924B2/en not_active Ceased
- 2008-12-19 CL CL2008003832A patent/CL2008003832A1/es unknown
- 2008-12-19 AR ARP080105608A patent/AR071279A1/es not_active Application Discontinuation
- 2008-12-19 PE PE2008002152A patent/PE20091526A1/es not_active Application Discontinuation
- 2008-12-19 TW TW097149926A patent/TW200940051A/zh unknown
-
2010
- 2010-05-20 TN TN2010000223A patent/TN2010000223A1/fr unknown
- 2010-05-30 IL IL206069A patent/IL206069A0/en unknown
- 2010-07-14 MA MA33012A patent/MA32013B1/fr unknown
- 2010-07-19 CO CO10087808A patent/CO6321234A2/es not_active Application Discontinuation
- 2010-07-19 CR CR11572A patent/CR11572A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008343924B2 (en) | 2013-01-17 |
| CL2008003832A1 (es) | 2010-03-26 |
| PE20091526A1 (es) | 2009-11-01 |
| EP2231595B1 (en) | 2014-04-23 |
| US8183293B2 (en) | 2012-05-22 |
| CN101903338A (zh) | 2010-12-01 |
| TW200940051A (en) | 2009-10-01 |
| TN2010000223A1 (en) | 2011-11-11 |
| JP2011507847A (ja) | 2011-03-10 |
| ES2471919T3 (es) | 2014-06-27 |
| WO2009085177A1 (en) | 2009-07-09 |
| US20090275659A1 (en) | 2009-11-05 |
| MA32013B1 (fr) | 2011-01-03 |
| EA201001029A1 (ru) | 2011-06-30 |
| EP2231595A1 (en) | 2010-09-29 |
| JP5437267B2 (ja) | 2014-03-12 |
| AU2008343924A2 (en) | 2011-02-17 |
| KR20100102668A (ko) | 2010-09-24 |
| CO6321234A2 (es) | 2011-09-20 |
| BRPI0821197A2 (pt) | 2015-06-16 |
| AR071279A1 (es) | 2010-06-09 |
| AU2008343924A1 (en) | 2009-07-09 |
| IL206069A0 (en) | 2010-11-30 |
| CA2707789A1 (en) | 2009-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123958T1 (el) | Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης | |
| CY1120390T1 (el) | Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων | |
| CY1124024T1 (el) | Νεες ctla4-ig ανοσοπροσκολλητινες | |
| DOP2019000287A (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) | |
| UY33314A (es) | Derivados de acido 1-amino-2-ciclopropiletilboronico | |
| CR20120522A (es) | Pirrolobenzodiacepinas y conjugados de las mismas | |
| CY1120556T1 (el) | Δικυκλικα ετεροκυκλα ως αναστολεις fgfr | |
| MX373141B (es) | Anticuerpos anti-homologo relacionado con las convulsiones 6 (anti-sez6) y metodos de uso. | |
| CL2017002122A1 (es) | Heterociclos bicíclicos como inhibidores de fgfr4 | |
| PE20160538A1 (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la via del factor tisular (tfpi) | |
| UY35023A (es) | Derivados c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso | |
| MX2016017296A (es) | Sintasa del acido cannabicromenico proveniente de cannabis sativa. | |
| CO2017002532A2 (es) | Indazoles sustituidos con bencilo como inhibidores de bub1 | |
| CY1115588T1 (el) | Αναστολεις ανθρωπινης πρωτεϊνικης φωσφατασης τυροσινης-β και η φαρμακευτικη χρηση τους | |
| CY1122115T1 (el) | Παραγωγα ν1-ακυλο-5-φθοροπυριμιδινονης | |
| GT201200153A (es) | Derivados del ácido carbamoil-metil-amino-acético sustituido como inhibidores de nep novedosos | |
| EA201590590A1 (ru) | Модуляторы рецептора андрогенов и их применение | |
| CO6331427A2 (es) | Inhibodores de beta -lactamasa | |
| BR112013005116A2 (pt) | moduladores e métodos de uso | |
| EA201390894A1 (ru) | Пиразолильные и пиримидинильные трициклические еноны в качестве антиоксидантных модуляторов воспаления | |
| EA201491817A1 (ru) | Терапевтическое применение продуктов из косточек винограда шардоне | |
| CR11572A (es) | Derivados del acido fenilacetico como moduladores de la inflamacion | |
| GT201200171A (es) | Derivados de fenilimidazol heteroaromáticos como inhibidores de enzima pde10a | |
| CY1119427T1 (el) | Τοπικη συνθεση που περιλαμβανει αλλαντικη τοξινη και μια χρωστικη | |
| MX2015003701A (es) | Composiciones para tratamiento. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |